3,3',5-triiodothyronamine has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, K; Rameshwar, J | 1 |
1 other study(ies) available for 3,3',5-triiodothyronamine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Antihyperglycaemic and antiperoxidative roles of acarbose in type 2 diabetes mellitus are possibly mediated through changes in thyroid function.
Topics: Acarbose; Animals; Antioxidants; Blood Glucose; Catalase; Dexamethasone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glutathione; Hypoglycemic Agents; Insulin; Kidney; Lipid Peroxidation; Mice; Myocardium; Superoxide Dismutase; Thyroid Gland; Thyroxine; Triiodothyronine | 2006 |